Nature of peritoneal macrophages from DCC immunized mice

A Damle1, P R Mahadevan

  • 1Radiation Medical Centre Parel, Bombay.

Indian Journal of Leprosy
|October 1, 1993
PubMed

Insights

Mice immunized with Mycobacterium leprae components showed activated peritoneal macrophages. These activated cells demonstrated enhanced phagocytosis and killing of M. leprae, indicating improved immune response against the pathogen.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Mycobacterium leprae is the causative agent of leprosy.
  • Understanding macrophage activation is crucial for developing effective leprosy treatments.
  • Previous research has shown that peritoneal macrophages can be activated.

Purpose of the Study:

  • To investigate the activation state of peritoneal macrophages in mice immunized with the delipidified cell component (DCC) of Mycobacterium leprae.
  • To assess the functional changes in these activated macrophages, specifically their ability to phagocytose and kill M. leprae.
  • To analyze the surface structure alterations in activated macrophages.

Main Methods:

  • Immunization of mice with Mycobacterium leprae delipidified cell component (DCC).
  • Isolation and analysis of peritoneal macrophages.
  • Measurement of cellular parameters including protein synthesis and hydrolytic enzyme levels.
  • Assessment of phagocytic ability and surface structure of macrophages.

Main Results:

  • Immunization with DCC led to significant changes in peritoneal macrophages.
  • Activated macrophages exhibited increased protein synthesis and hydrolytic enzyme levels.
  • Enhanced phagocytic ability and altered surface structures were observed in activated macrophages.
  • These activated macrophages showed improved capacity to phagocytose and kill M. leprae.

Conclusions:

  • Peritoneal macrophages are activated by immunization with Mycobacterium leprae DCC.
  • Activated macrophages display enhanced functional capabilities, including improved phagocytosis and killing of M. leprae.
  • Surface structure modifications correlate with macrophage activation and improved pathogen clearance.
  • These findings support the potential of DCC as an immunomodulator for enhancing host defense against M. leprae.

Related Concept Videos